ZEB2 Antibodies

Santa Cruz Biotechnology features a diverse variety of ZEB2 monoclonal antibodies for research focused on understanding ZEB2 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).ZEB2, also known as Zinc Finger E-Box Binding Homeobox 2, is a transcription factor that plays a critical role in the regulation of epithelial-mesenchymal transition (EMT), a process essential for development and tissue repair. Dysregulation of ZEB2 has been implicated in various cancers, making it a significant target for therapeutic intervention. Understanding ZEB2 function is vital for elucidating its contributions to cellular processes and disease mechanisms. ZEB2 monoclonal antibodies enable researchers to explore protein expression patterns across different tissues and cell types. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates provide flexibility in experimental design. Santa Cruz Biotechnology monoclonal antibodies for ZEB2 research support scientists worldwide in advancing our understanding of cancer biology and developmental processes.